Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
01/04/2012 | CN102307896A Fibronectin type III domain based scaffold compositions, methods and uses |
01/04/2012 | CN102307894A A variant of mite allergen and uses thereof |
01/04/2012 | CN102307891A WDRPUH epitope peptides and vaccines containing the same |
01/04/2012 | CN102304535A Gene of encoding lignan-methylating enzyme |
01/04/2012 | CN102304527A Enterococcus antigens |
01/04/2012 | CN102304525A Flowering regulating gene AcFT and application thereof |
01/04/2012 | CN102304524A Rice endosperm specific promoter |
01/04/2012 | CN102304519A Regulation and control of small molecular ribonucleic acid (RNA) on auxin response factor (ARF) gene and application thereof in production |
01/04/2012 | CN102304497A Gene Gbyucca10 associated with improvement on lint content in cotton and use thereof |
01/04/2012 | CN102304493A Monoclonal antibody against riemerella anatipestifer (RA) |
01/04/2012 | CN102304492A Primary culture method for liver cells of crucian carp |
01/04/2012 | CN102304491A Method for establishing and identifying cynoglossus semilaevis testis cell line |
01/04/2012 | CN102304181A Monoclonal antibody of avian leukosis virus subgroup J surface protein and preparation method thereof |
01/04/2012 | CN102304180A Monoclonal antibody of avian reticuloendotheliosis virus envelope protein and preparation method thereof |
01/04/2012 | CN102304175A Protein GmMYB118 related to fatty acid synthesis, coding gene and application thereof |
01/04/2012 | CN102304169A Antihypertensive polypeptide and use thereof |
01/04/2012 | CN102302788A Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
01/04/2012 | CN101899424B Protein related to synthesis of mono-vinyl chlorophyll a and coding gene thereof |
01/04/2012 | CN101792738B Cell strain of monoclonal antibody against ciprofloxacin and monoclonal antibody thereof |
01/04/2012 | CN101698844B Promoter from corynebacterium glutamicum and application thereof |
01/04/2012 | CN101580545B Monoclonal antibody of hemagglutinin protein resisting H5N1 resource and application thereof |
01/04/2012 | CN101418330B Non protein culture medium adapted to large-scale culture of NSO cell and production of antibody |
01/04/2012 | CN101376890B Method for converting island cotton by agrobacterium-mediated transformation |
01/04/2012 | CN101357942B Monoclonal antibody, Fab antibody and application for neutralizing enterohemorrhagic escherichia coli o157:H7 shiga toxin II |
01/04/2012 | CN101273134B Glp/1/exendin 4 igg fc fusion constructs for treatment of diabetes and method |
01/04/2012 | CN101269242B Transgenic cell overlapped vascular inner rack and manufacture method thereof |
01/04/2012 | CN101194593B Group cultivation and rapid breeding method for sarcandra glabra |
01/04/2012 | CN101157909B HEL transformation cell lines for producing biologicals |
01/04/2012 | CN101018863B Mutant pneumolysin proteins |
01/03/2012 | US8088980 Celery cultivar ADS-15 |
01/03/2012 | US8088974 Production of polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs |
01/03/2012 | US8088972 Glyphosate-N-acetyltransferase (GAT) genes |
01/03/2012 | US8088969 Swine population having low levels of porcine endogenous retrovirus and uses thereof |
01/03/2012 | US8088968 Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation |
01/03/2012 | US8088909 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
01/03/2012 | US8088906 FAD4, FAD5, FAD5-2, and FAD6, novel fatty acid desaturase family members and uses thereof |
01/03/2012 | US8088893 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions |
01/03/2012 | US8088813 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
01/03/2012 | US8088622 P27 and P21 in gene therapies |
01/03/2012 | US8088619 Established Maruca vitrata cell line |
01/03/2012 | US8088618 Anti-IL 13 antibodies and uses thereof |
01/03/2012 | US8088617 Antibodies that bind the glutamate ligand binding region of Notch1 |
01/03/2012 | US8088585 Methods for purifying hematopoietic stem cells |
01/03/2012 | US8088568 Dermal micro-organs, methods and apparatuses for producing and using the same |
01/03/2012 | US8088567 Human immortalised neural precursor cell line |
01/03/2012 | US8088377 Human monoclonal antibodies against CD30 |
01/03/2012 | US8088371 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; coat suture, stent, screw, plate implants with plasma |
01/03/2012 | US8088370 Compositions and methods of vascular injury repair |
01/03/2012 | US8088160 Drug-eluting intravascular prostheses and methods of use |
01/03/2012 | CA2690293C Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
01/03/2012 | CA2632247C Cryopreservation of hepatocytes |
01/03/2012 | CA2577280C Sample movement control unit, sample movement parameters acquisition method, and sample movement control method |
01/03/2012 | CA2514873C Compositions and methods for inhibiting tumor growth and metastasis |
01/03/2012 | CA2501708C Mammalian artificial chromosome |
01/03/2012 | CA2501087C Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer |
01/03/2012 | CA2483756C Method for preparing tissue constructs |
01/03/2012 | CA2480423C Truncated 24 kda basic fibroblast growth factor |
01/03/2012 | CA2466054C Apo-2 ligand/trail formulations |
01/03/2012 | CA2436049C A serpin in bifidobacteria |
01/03/2012 | CA2420618C Percarboxylated polysaccharides, and a process for their preparation |
01/03/2012 | CA2417643C Mutant egiii cellulase, dna encoding such egiii compositions and methods for obtaining same |
01/03/2012 | CA2416801C Adult human dental pulp stem cells in vitro and in vivo |
01/03/2012 | CA2413258C Interferon-like protein zcyto21 |
01/03/2012 | CA2348698C Variants of humanized anti-carcinoma monoclonal antibody cc49 |
01/03/2012 | CA2343571C Stable neural stem cell lines |
01/03/2012 | CA2330938C Enzyme |
01/03/2012 | CA2307638C Multiply-substituted protease variants |
01/03/2012 | CA2304952C Mannose-receptor bearing cells and antigen conjugate for immunotherapy |
01/03/2012 | CA2282719C A method for producing procollagen |
01/03/2012 | CA2226973C Modulators of the function of fas receptors and other proteins |
01/03/2012 | CA2221092C Genetic control of flowering |
01/03/2012 | CA2217539C Urinary bladder submucosa derived tissue graft |
01/03/2012 | CA2210998C Inhibition of neovascularization using vegf-specific oligonucleotides |
01/03/2012 | CA2178482C Thrombopoietin |
12/29/2011 | WO2011163531A2 Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases |
12/29/2011 | WO2011163478A2 Dual variable domain immunoglobulins and uses thereof |
12/29/2011 | WO2011163328A2 Methods for producing tissue scaffold directing differentiation of seeded cells and tissue scaffolds produced thereby |
12/29/2011 | WO2011162826A2 Group culture system and method with helper embryos |
12/29/2011 | WO2011162623A1 Stem cell population and methods of isolation and use thereof |
12/29/2011 | WO2011162115A1 PHARMACEUTICAL COMPOSITION UTILIZING PANCREATIC β CELL PROLIFERATION FACTOR |
12/29/2011 | WO2011161970A1 Anti-pdgf receptor antibody |
12/29/2011 | WO2011161962A1 Method and device for identifying multipotent stem cell colony, and method and device for automatic culturing of multipotent stem cells |
12/29/2011 | WO2011161611A1 Method for selecting mevalonate synthesis modulators using cells derived from human pluripotent cells |
12/29/2011 | WO2011161437A1 Methods for cartilage repair using tfgbeta and fgf - 2 |
12/29/2011 | WO2011161174A1 Method for harvesting cells cultured in 3d hydrogel matrices |
12/29/2011 | WO2011161172A1 Improved crosslinked hyaluronan hydrogels for 3d cell culture |
12/29/2011 | WO2011123166A3 Methods and systems for reducing dna fragmentation in a processed sperm sample |
12/29/2011 | WO2011112671A3 Conversion of vascular endothelial cells into multipotent stem-like cells |
12/29/2011 | WO2011097573A3 Methods and compositions for cancer immunotherapy using flagellin-tumor associated antigen fusion protein expressing tumor cells |
12/29/2011 | WO2011091350A3 Methods & compositions for improving protein production |
12/29/2011 | WO2011090297A3 Human adult stem cell for expressing anti-mdm2, and use thereof |
12/29/2011 | WO2011088155A3 Materials and methods for producing cell-surface directed and associated non-naturally occurring bioinorganic membranes and uses thereof |
12/29/2011 | WO2011085247A4 Vectors and methods for transducing b cells |
12/29/2011 | WO2011072247A3 Pathogen restriction factors |
12/29/2011 | WO2008019351A8 Compositions and their uses directed to diacylglycerol acyltransferase 1 |
12/29/2011 | US20110321200 Rejuvenation or preservation of germ cells |
12/29/2011 | US20110321197 Plants with Increased Yield (NUE) |
12/29/2011 | US20110321196 Nucleic Acid Sequences Encoding Proteins Associated with Abiotic Stress Response |
12/29/2011 | US20110321195 Lyso-Phosphatidic Acid Acyltransferase from Tropaeolum Majus |
12/29/2011 | US20110321193 Method And Compositions for the Production of Transgenic Plants |